Insight Molecular Diagnostics Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/877d4a8e-588a-426a-887e-231fcbfe47bd/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $4.1M | 2025-01-01 – 2025-12-31 | evidence 0001642380-26-000004 |
| FY 2024 | $1.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-043852 |
| FY 2023 | $1.5M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014720 |
| FY 2022 | $958.0k | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-012005 |
| FY 2021 | $2.2M | 2021-01-01 – 2021-12-31 | evidence 0001493152-23-012005 |
| FY 2020 | $1.2M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006465 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001140361-16-065775 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Insight Molecular Diagnostics Inc. — all facts · Net Income · Operating Income